Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Astellas enters agreements to research new anti-dengue virus drugs

March 25, 2013

Cancer research institutions collaborate with Janssen to discover multiple myeloma drug

March 25, 2013

Cerecor obtains worldwide rights to Merck & Co.'s COMT inhibitors

March 22, 2013

UCB and Five Prime Therapeutics enter collaboration

March 21, 2013

NPS Pharmaceuticals regains rights to teduglutide and PTH 1-84

March 20, 2013

Merck Serono and Bristol-Myers Squibb to promote Glucophage in China

March 20, 2013

Venaxis enters commercial development agreements for its appendicitis test

March 20, 2013

Personal Genome Diagnostics licenses rights to genome mapping technology

March 19, 2013

Modified western blot assay detects Plasmodium circumsporozoite protein

March 19, 2013

Harvard's Wyss Institute and Sony DADC enter collaboration for Organs-on-Chips technologies

March 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...